2024-07-20 06:00:00 ET
California's giant redwood trees were once tiny sprouts or seeds. Likewise, the world's biggest companies were once much smaller. Trees and companies can grow significantly over time -- at least some of them.
Three Motley Fool contributors think they've found biotech stocks that have the potential to become much larger. Here's why they think CRISPR Therapeutics (NASDAQ: CRSP) , Zealand Pharma (OTC: ZLDP.F) , and Viking Therapeutics (NASDAQ: VKTX) are monster stocks in the making to buy right now.
Prosper Junior Bakiny (CRISPR Therapeutics): It's always an important milestone for a clinical-stage biotech to launch its first product. That's what happened with CRISPR Therapeutics last year. The gene-editing specialist earned approval for Casgevy, developed in collaboration with Vertex Pharmaceuticals , to treat sickle cell disease (SCD) and transfusion-dependent beta-thalassemia (TDT).
For further details see:
3 Monster Stocks in the Making to Buy Right Now